Substance Use Interactive Interpreter

CRAFFT: Adolescent Substance Use Screening Tool

The CRAFFT (Car, Relax, Alone, Forget, Friends, Trouble) is a 6-item AAP-recommended screener for alcohol and drug use in adolescents aged 12–21. Score ≥2 is a positive screen for high-risk substance use or a substance use disorder.

CRAFFT Score Interpreter

Positive Screen

Indicates high-risk use. A brief motivational intervention and referral for a full substance use assessment are recommended.

6 yes/no items; each 'Yes' = 1 point. Total range 0–6. Higher scores indicate greater substance use risk.

Total score (Part B)Interpretation
4+High RiskHigh probability of a substance use disorder. Refer for a comprehensive substance use evaluation and consideration of treatment.
2–3Positive ScreenIndicates high-risk use. A brief motivational intervention and referral for a full substance use assessment are recommended.
0–1Negative ScreenLow-risk result. Brief positive feedback and anticipatory guidance about substance use are still recommended as part of preventive care.

Knight JR et al. (2002); Mitchell SG et al. (2014). ≥2 cutoff validated against DSM criteria. Score gradations above ≥2 reflect clinical convention rather than a separately validated threshold. Educational reference only — not a diagnostic tool.

For reference only — not an assessment, diagnosis, or medical advice. This page provides scoring reference material; interpretation and clinical decisions rest with a qualified clinician.

What the CRAFFT measures

The CRAFFT (Car, Relax, Alone, Forget, Friends, Trouble) was developed by John R. Knight and colleagues at the Center for Adolescent Substance Abuse Research (CeASAR) at Boston Children's Hospital (2002). It is the most validated and widely recommended substance use screening tool for adolescents aged 12–21, endorsed by SAMHSA, the American Academy of Pediatrics (AAP), and NIDA.

The American Academy of Pediatrics (AAP) recommends annual substance use screening for all adolescents as part of preventive health visits. The most current version, CRAFFT 2.1, addresses evolving patterns including electronic cigarettes and prescription drug misuse.

The CRAFFT v2.1 assesses alcohol and drug use risk in adolescents across two stages:

Part A (initial screen): Three questions about alcohol, marijuana, and other substance use in the past 12 months.

  • If the patient answers "No" to all three, only the "Car" question is required.
  • If any Part A answer is "Yes," all six CRAFFT questions are administered.

Part B (CRAFFT acronym items):

  • C, Car: Have you ever ridden in a CAR driven by someone (including yourself) who was "high" or had been using alcohol or drugs?
  • R, Relax: Do you ever use alcohol or drugs to RELAX, feel better about yourself, or fit in?
  • A, Alone: Do you ever use alcohol or drugs while you are by yourself, ALONE?
  • F, Forget: Do you ever FORGET things you did while using alcohol or drugs?
  • F, Friends: Do your FAMILY or FRIENDS ever tell you that you should cut down on your drinking or drug use?
  • T, Trouble: Have you ever gotten into TROUBLE while you were using alcohol or drugs?

How to administer the CRAFFT

  1. Part A: Ask about past-12-month use of alcohol, marijuana, and other substances.
  2. Part B: Administer the 6 CRAFFT questions. If Part A was negative, only the "Car" question is strictly required, though completing all 6 provides a full score.
  3. Scoring: Sum all "Yes" responses from Part B.
  4. Action: Deliver brief counselling based on the score range.

The CRAFFT can be self-administered or administered verbally by a clinician. Confidentiality should be clearly communicated to the adolescent regardless of format.

CRAFFT scoring and interpretation

Each item is scored Yes (1) or No (0). Total score: 0–6.

Score ranges:

  • 0–1: Negative Screen. Low risk; brief positive feedback and anticipatory guidance recommended.
  • 2–3: Positive Screen. High-risk use; brief motivational intervention and consider referral to substance use assessment.
  • 4–6: High Risk. High probability of a substance use disorder; refer to detailed substance use evaluation and treatment.

Clinical threshold:

  • ≥2 is the validated cutoff for identifying adolescents who may benefit from a full assessment or intervention (Knight et al., 2002; Mitchell et al., 2014). The 4–6 band reflects clinical convention rather than a separately validated threshold.

Psychometric properties

  • Reliability: Good internal consistency (α = 0.68–0.80).
  • Validity: In 538 adolescents aged 14–18 at a hospital-based clinic, CRAFFT scores correlated strongly with diagnostic classification (Spearman rho 0.72). At a cutoff of ≥2, sensitivity was 0.76 and specificity 0.94 for any problem (problem use, abuse or dependence), 0.80 and 0.86 for any disorder, and 0.92 and 0.80 for dependence. Validity was not significantly affected by age, sex, or race (Knight et al., 2002).
  • DSM-5: In 525 primary care patients aged 12–17, the AUC was 0.93 for problem use and 0.97 for DSM-5 substance use disorder, and the cut-point of 2 remained optimal (Mitchell et al., 2014).
  • Populations: Validated for ages 12–21 in primary care, emergency departments, and school health settings.

Limitations

  • Screening, not diagnosis: a positive screen calls for a comprehensive clinical evaluation.
  • Does not differentiate by substance type in the final score.
  • Self-report is subject to social desirability effects; confidentiality is critical.
  • Not designed for youth under age 12.
For reference only — not an assessment, diagnosis, or medical advice. This page provides scoring reference material; interpretation and clinical decisions rest with a qualified clinician.

This library is an academic and clinical reference. A scale described here is not necessarily offered in HiBoop; each page says whether it is.

Frequently Asked Questions

What does a CRAFFT score of 2 or higher mean?

A score of 2 or higher is the validated positive screen threshold, indicating a significant risk of a substance use disorder or high-risk substance use. At this cutoff, the original validation study found sensitivity of 76% and specificity of 94% for any substance-related problem (problem use, abuse or dependence), and sensitivity of 80% and specificity of 86% for any substance use disorder. A positive screen should prompt a more thorough clinical assessment, not a diagnosis.

Is the CRAFFT self-report or clinician-administered?

The CRAFFT can be self-administered or administered verbally by a clinician. Both formats are widely used in primary care and school health settings. Confidentiality should be clearly communicated to the adolescent regardless of format, as it substantially improves honest disclosure.

Can the CRAFFT diagnose a substance use disorder?

No. The CRAFFT is a brief screening tool, not a diagnostic tool. A positive screen (score ≥2) identifies adolescents who are likely to benefit from a comprehensive clinical evaluation. A formal substance use disorder diagnosis requires a structured clinical interview using established criteria such as DSM-5.

What age range is the CRAFFT designed for?

The CRAFFT is validated for adolescents aged 12–21. It is not intended for use in children under 12. The American Academy of Pediatrics recommends its use as part of annual preventive health visits throughout adolescence.

Bill this assessment

In the US, the CRAFFT: Adolescent Substance Use Screening Tool is usually billed under these CPT codes. Payer rules vary.

What's Next

Using this assessment in practice

For clinicians

Send it as a gentle check-in before the session. The score is waiting when you open the chart, and the trend builds itself.

For individuals

This page is a clinical reference, not a diagnostic tool. If you have concerns about your own symptoms, bring this information to a qualified mental health professional.

References

  1. 1.
    Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607-614.View source
  2. 2.
    Mitchell SG, Kelly SM, Gryczynski J, Myers CP, O'Grady KE, Kirk AS, Schwartz RP. The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination. Subst Abus. 2014;35(4):376-380.View source
  3. 3.
    Lee CA, Smith DC, Lanker A, Clary KL. Sensitivity and specificity of the CRAFFT to identify heavy cannabis use: Evidence from a large statewide adolescent sample. Addict Behav. 2021;122:107006.View source

Last reviewed: Jun 3, 2026